home / stock / bngo / bngo news


BNGO News and Press, Bionano Genomics Inc. From 09/11/23

Stock Information

Company Name: Bionano Genomics Inc.
Stock Symbol: BNGO
Market: NASDAQ
Website: bionanogenomics.com

Menu

BNGO BNGO Quote BNGO Short BNGO News BNGO Articles BNGO Message Board
Get BNGO Alerts

News, Short Squeeze, Breakout and More Instantly...

BNGO - The 3 Best High-Risk, High-Reward Stocks to Buy Now: September 2023

2023-09-11 04:06:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Due to a combination of worries about high-interest rates, China’s decision to prevent some government employees from using Apple’s (NASDAQ: AAPL ) iPhones at work...

BNGO - Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia

SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from researchers at the German Cancer Consortium (DKTK) showing the utility of optical genome mapping (OGM) and whole-exome sequencing (WES) in better understanding...

BNGO - AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley

2023-09-04 12:00:00 ET More on AI Cathie Wood's 'Big Ideas 2023' sees Artificial Intelligence as the future Artificial intelligence is a '1995 moment' for tech. That could push stocks even higher Apple CEO Tim Cook says artificial intelligence 'is a major focus of ou...

BNGO - SNDL, BNGO and MDB are among pre market gainers

2023-09-01 08:24:18 ET Eos Energy Enterprises ( EOSE ) +52% announces $500M project to address long-duration energy storage demand. TRxADE HEALTH ( MEDS ) +30% . 23andMe Holding ( ME ) +20% rises 17% on FDA clearance to report more genetic variants. Nut...

BNGO - Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development

SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM) as an alternative to karyotyping (KT) and chromosomal microarray (CMA) for the evaluation of...

BNGO - Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health

Bionano original equipment manufacturing (OEM) partner A-smart MedTech (A-smart) obtained reagent class I registration and approval for DNA isolation and labeling kits for optical genome mapping (OGM) from China's National Medical Products Administration (NMPA) Reagents can be utilized for ...

BNGO - Bionano regains compliance with Nasdaq minimum bid price listing requirement

2023-08-21 16:34:58 ET More on Bionano Genomics Bionano Genomics: A Noble Cause But A Bad Investment Bionano Genomics announces CFO transition, appointment of Kama as CFO Bionano gains as early Q1 revenue exceeds consensus Seeking Alpha’s Quant Rating ...

BNGO - Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has received a letter from the staff of the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained complian...

BNGO - Catalyst watch: Nvidia earnings, Twilio event, AMC drama and Jackson Hole jitters

2023-08-18 15:00:03 ET More on the market Jackson Hole: Fed Faces Ghosts Of 1970s As Stock Market Rollercoaster Continues Resolving An Overbought Condition For The Stock Market Dollar Bulls Still In Control Why I Stopped Buying The S&P 500 To Buy REITs Inst...

BNGO - Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory

SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has received Laboratory Accreditation from the College of American Pathologists (CAP) for its Clinical Laboratory Improvement Amendme...

Previous 10 Next 10